GlaxoSmithKline (GSK) Tops Q3 EPS by 1c

GlaxoSmithKline (NYSE: GSK) reported Q3 EPS of GBP0.33, GBP0.01 better than the analyst estimate of GBP0.32. Revenue for the quarter came in at GBP7.84 billion versus the consensus estimate of GBP7.86 million.

For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• Enerpac Tool Group to buy SFE Group for $472 million
• Principal Financial Group to acquire Beam Benefits, a small-business insurer